Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease
10.1016/j.antiviral.2011.07.002
Saved in:
Main Authors: | Schüller, A., Yin, Z., Brian Chia, C.S., Doan, D.N.P., Kim, H.-K., Shang, L., Loh, T.P., Hill, J., Vasudevan, S.G. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110333 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Engineering Dengue virus NS3 Protease for structural studies
by: CASEY LAUREN SAUTTER
Published: (2011) -
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development
by: Luo, Dahai, et al.
Published: (2016) -
Structure-guided fragment-based in silico drug design of dengue protease inhibitors
by: Knehans, T., et al.
Published: (2014) -
Dynamic interactions of post cleaved NS2B cofactor and NS3 protease identified by integrative structural approaches
by: Quek, Jun-Ping, et al.
Published: (2022) -
Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity
by: Doan, D.N.P., et al.
Published: (2014)